在2024中(zhong)(zhong)國創新器械與智(zhi)能制(zhi)(zhi)造榜(bang)(bang)TOP100、中(zhong)(zhong)國創新醫藥(yao)與生物制(zhi)(zhi)品榜(bang)(bang)TOP100、中(zhong)(zhong)國醫療(liao)與健(jian)康(kang)創新服務榜(bang)(bang)TOP100、中(zhong)(zhong)國醫療(liao)健(jian)康(kang)產(chan)業(ye)鏈服務榜(bang)(bang)TOP100四張主榜(bang)(bang)單(dan)中(zhong)(zhong)，共計有(you)400家企(qi)業(ye)上(shang)榜(bang)(bang)，總估(gu)值(zhi)約1.26萬億(yi)元(yuan)(yuan)，總平(ping)均(jun)估(gu)值(zhi)同比回升約2.74%。其中(zhong)(zhong)，有(you)86.75%的上(shang)榜(bang)(bang)企(qi)業(ye)估(gu)值(zhi)集中(zhong)(zhong)于10-60億(yi)元(yuan)(yuan)區間，構成大健(jian)康(kang)產(chan)業(ye)非(fei)上(shang)市公(gong)司(si)主要群(qun)體；12家企(qi)業(ye)估(gu)值(zhi)突破百億(yi)；2家企(qi)業(ye)估(gu)值(zhi)在200億(yi)元(yuan)(yuan)以上(shang)；估(gu)值(zhi)排名TOP10企(qi)業(ye)估(gu)值(zhi)均(jun)值(zhi)達145.2億(yi)元(yuan)(yuan)。

地區分(fen)布(bu)上，長三(san)角經(jing)濟區、粵港澳(ao)經(jing)濟區仍是大(da)(da)健(jian)康(kang)(kang)企(qi)(qi)業的(de)成長沃土(tu)；深(shen)圳、杭州為(wei)(wei)大(da)(da)健(jian)康(kang)(kang)企(qi)(qi)業駐(zhu)地第二梯(ti)隊(dui)；廣(guang)州、蘇州為(wei)(wei)大(da)(da)健(jian)康(kang)(kang)企(qi)(qi)業駐(zhu)地第三(san)梯(ti)隊(dui)；以成都市為(wei)(wei)核心的(de)西部經(jing)濟圈大(da)(da)健(jian)康(kang)(kang)產(chan)業正在(zai)快速(su)崛(jue)起，成為(wei)(wei)醫療健(jian)康(kang)(kang)企(qi)(qi)業西部聚集高(gao)地。